Dr. Harpreet Singh Bhatia, MAS, MD

Dr. Bhatia practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Bhatia's NPI, 1750709168, was assigned on April 2, 2014. Dr. Bhatia graduated from Emory School of Medicine in 2014. Dr. Bhatia's California license number on file is A155303.

Dr. Bhatia's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Bhatia's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Bhatia is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhatia practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Bhatia's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Bhatia is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Bhatia's licenses on file in 2 states: California and New York.

Dmand AI lists atrial fibrillation and flutter, cardiac arrhythmia, cardiomyopathy, chest pain, chronic hypertension, circulation problems, congestive heart failure and coronary artery disease among the conditions Dr. Bhatia treats.

CMS data shows 482 Medicare services from Dr. Bhatia across 5 procedure codes in 2024, for 291 Medicare patients. Medicare paid $30,819 for them.

CMS counts 291 Medicare patients who saw Dr. Bhatia in 2024. The largest group is 75 to 84, with 115 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bhatia's median patient age at 68, with 50% women.

In 2024, Dr. Bhatia wrote 1,332 Medicare Part D claims for 276 patients. 76% of them were for generic drugs. CMS names the drug for 1,168 of them, across 26 drugs with 11 or more claims each, at $261,699 in total drug cost. In 2023, CMS named 707 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bhatia for performance year 2024, reported as part of a group. Dr. Bhatia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhatia as offering telehealth.

Dmand AI links 57 papers to Dr. Bhatia, published from 2010 to 2025. 2024 was the busiest year, with 12. The most frequent topics are Lipoprotein(a), Atherosclerosis and Cardiovascular Diseases. Dr. Bhatia has published most often in Atherosclerosis. Dr. Bhatia's most frequent co-authors are Sotirios Tsimikas, MD, Matthew J. Budoff, MD and Michael Honore Criqui, MD.

CMS Open Payments shows 50 general payments to Dr. Bhatia from 13 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 81% of the total. Kaneka Pharma America LLC paid the most, $11,000. It also lists 4 research payments totaling $16,656 from 2024 to 2025.

Dr. Bhatia graduated from Emory School of Medicine in 2014.

Dr. Bhatia is in network with 13 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 8. Check the plan with the practice before a visit.